Implementing preexposure prophylaxis among key populations: an opportunity for patient-centered services and management of hepatitis B

When taken properly, Tenofovir-based oral preexposure prophylaxis (PrEP) has been proven to be efficient to prevent HIV acquisition [1–5]. Since 2015, PrEP is recommended by the WHO for populations at ‘substantial risk’ of HIV [6]. However, WHO points out the need for additional research on PrEP in

[1]  J. Larmarange.  The challenges of implementing PrEP : the case of female sex workers in Côte d'Ivoire – Joseph Larmarange , 2019 .

[2]  J. Larmarange,et al.  Social and implementation research for ending AIDS in Africa. , 2017, The Lancet. Public health.

[3]  M. Wainberg,et al.  Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study. , 2017, The lancet. HIV.

[4]  Ratana Somrongthong,et al.  Barriers to sexual and reproductive healthcare services as experienced by female sex workers and service providers in Dhaka city, Bangladesh , 2017, PloS one.

[5]  N. Ippoliti,et al.  Meeting the Reproductive Health Needs of Female Key Populations Affected by HIV in Low- and Middle-Income Countries: A Review of the Evidence. , 2017, Studies in family planning.

[6]  C. Silvestri,et al.  Emerging Trends in Epidemiology of Hepatitis B Virus Infection , 2017, Journal of clinical and translational hepatology.

[7]  V. Ridde,et al.  The implementation of public health interventions in Africa: a neglected strategic theme. , 2017, Medecine et sante tropicales.

[8]  C. Tremblay,et al.  Costs and benefits of On-Demand HIV Pre-Exposure Prophylaxis in Men Who Have Sex with Men Analysis of the ANRS IPERGAY study with a one-year follow-up. , 2017, AIDS.

[9]  Sheena McCormack,et al.  Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial , 2016, The Lancet.

[10]  David Thompson,et al.  On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection. , 2015, The New England journal of medicine.

[11]  Mario Chen,et al.  Understanding the Broader Sexual and Reproductive Health Needs of Female Sex Workers in Dhaka, Bangladesh. , 2015, International perspectives on sexual and reproductive health.

[12]  S. Baral,et al.  An Urgent Need for Integration of Family Planning Services Into HIV Care: The High Burden of Unplanned Pregnancy, Termination of Pregnancy, and Limited Contraception Use Among Female Sex Workers in Côte d'Ivoire , 2015, Journal of acquired immune deficiency syndromes.

[13]  Megha L Mehrotra,et al.  Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. , 2014, The Lancet. Infectious diseases.

[14]  C. Hendrix,et al.  Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial , 2013, The Lancet.

[15]  James D. Campbell,et al.  Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. , 2012, The New England journal of medicine.

[16]  J. Stockman,et al.  Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men , 2012 .